Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEPT7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PGM5-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ULK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HES1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPIB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1orf216 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WNK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBBP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIPG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYGB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF532 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HEY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIGIT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASH2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on